Also known as A-3 vessel peptide · vascular peptide complex
A natural blood-vessel peptide complex (Cytomax A-3) — the extract-based counterpart to Vesugen, targeting vascular tissue.
Research refreshed
Ventfort is a natural peptide complex extracted from vascular (blood-vessel) tissue (peptide complex A-3), part of the Russian Cytomax / Revilab bioregulator line. It is the extract-based vascular counterpart to the synthetic tripeptide Vesugen (Lys-Glu-Asp), marketed within the Khavinson tradition for endothelial and vascular support.
Ventfort is the vessel-directed natural bioregulator of the Cytomax / Revilab line. It pairs with Vesugen, the synthetic Lys-Glu-Asp tripeptide already in this catalog: Ventfort is the natural vascular extract, Vesugen the defined synthetic short peptide modeled on the same tissue. In Khavinson protocols it is treated as a foundational entry because vascular function underlies every organ.
As a tissue extract it is a standardized polypeptide fraction with no single molecular formula or sequence. Its vascular claims come from the same concentrated research tradition as the rest of the series, with limited independent replication, and it is not FDA-approved.
Proposed tissue-selective (bioregulator) modulation of vascular / endothelial gene expression, in the same lineage as the synthetic vessel peptide Vesugen.
Behind every vial of Ventfort is the same exacting pipeline every research peptide runs — but the chemistry plays out differently for this molecule. Here is how Ventfort, specifically, is brought into being.
Ventfort begins not as a powder but as a specification. Before a single bond is made, the target sequence, salt form, and purity threshold are written down as the contract the finished material must meet.
Ventfort is assembled by solid-phase peptide synthesis — the chain grows one protected residue at a time on resin, and what you fail to build cleanly here you pay to remove later.
The crude mixture — Ventfort plus its deletions and side products — is then separated on preparative HPLC, and where the cut is taken decides the difference between a genuinely pure peptide and a barely-passable one.
A real batch of Ventfort proves itself: identity confirmed by mass spectrometry, purity read directly off an analytical HPLC trace, water and counterion content measured. That batch-specific certificate of analysis is the only honest way to know what is actually in a vial of Ventfort — and a short, cold, accountable chain of custody is how that purity survives the trip to your bench.
Ventfort is a natural blood-vessel peptide extract (complex A-3), a fractionated polypeptide preparation rather than a synthesized peptide. As with the other Cytomax extracts, consistency and characterization of the fraction are the quality challenge.
Don't judge a vial by its cake. A fluffy, good-looking lyophilized powder reflects bulking agents and freeze-drying parameters — not purity. Insist on a batch-specific certificate of analysis.
Ventfort is a natural blood-vessel peptide complex (Cytomax A-3), marketed for vascular and endothelial support — the extract-based counterpart to the synthetic peptide Vesugen.
Ventfort is the natural vascular extract; Vesugen is the defined synthetic tripeptide (Lys-Glu-Asp) modeled on the same tissue.
No — it is a tissue extract (a polypeptide fraction), so it has no single sequence or molecular formula.
No — it is a research compound / supplement, not FDA-approved. This page is a research and educational reference.
Synthetic tetrapeptide investigated for telomerase activity and circadian effects.
ViewThe natural pineal peptide bioregulator — the animal-derived counterpart to synthetic Epitalon, marketed for aging and telomere support.
ViewThymus-derived polypeptide complex — the founding tissue bioregulator (Cytomax) studied for immune restoration.
ViewDosing protocols, mechanism, comparisons, and the latest trials — citation-backed answers grounded in PubMed, PubChem, and ClinicalTrials.gov.